Medpace ยท 1 day ago
Clinical Data Review Associate - Infectious Disease/Renal/Rare Disease
Medpace is a full-service clinical contract research organization that provides Phase I-IV clinical development services. They are seeking a Clinical Data Review Associate to join their Clinical Coding & Support team, where the role involves reviewing clinical data and developing guidelines for therapeutic areas.
BiotechnologyPharmaceutical
Responsibilities
Comprehensive manual review of clinical data collected in trials
Development of clinical review guidelines for specific therapeutic areas
Interface with Data Management team to assure query resolution
Qualification
Required
Bachelor's of Science in Nursing and RN required
At least 3-4 years of nursing experience
1-2 years of specific therapeutic experience (i.e. cardiology, infectious disease, oncology, endocrine)
General knowledge of clinical trial processes and/or experience working with clinical data
Preferred
Familiarity with Microsoft Excel
Benefits
Flexible work environment
Competitive PTO packages, starting at 20+ days
Competitive compensation and benefits package
Company-sponsored employee appreciation events
Employee health and wellness initiatives
Community involvement with local nonprofit organizations
Discounts on local sports games, fitness gyms and attractions
Modern, ecofriendly campus with an on-site fitness center
Structured career paths with opportunities for professional growth
Discounted tuition for UC online programs
Company
Medpace
Medpace, Inc., a clinical research organization, provides clinical development services for pharmaceutical and biotechnology
H1B Sponsorship
Medpace has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (29)
2024 (21)
2023 (19)
2022 (22)
2021 (22)
2020 (16)
Funding
Current Stage
Public CompanyTotal Funding
unknown2016-08-10IPO
2014-02-24Acquired
Recent News
MarketScreener
2025-11-19
2025-10-27
2025-10-25
Company data provided by crunchbase